Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Millan

Showing results (151-160 of 496) with videos related to

Pageof 50
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1989
Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of actionM J Millan, A Członkowski, A Lipkowski, et al.
European Journal of Pharmacology|October 18, 1988
Antinociceptive effects of mu- and kappa-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanismC Stein, M J Millan, A Yassouridis, et al.
Journal of Neurochemistry|May 30, 2007
Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formationFrancesca Novi, Mark J Millan, Giovanni U Corsini, et al.
Acta Leprologica|January 1, 1986
[HLA and leprosy in Dakar: distribution of histocompatibility antigens in leprous patients and their relationship to ENL reactions]G Blavy, D Thiam, B Ndoye, et al.
British Journal of Pharmacology|November 11, 1999
Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: antagonism of the effects of clozapine by modafinilC Sebban, B Tesolin-Decros, M J Millan, et al.
European Journal of Pharmacology|June 20, 1996
S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptorsA Newman-Tancredi, C Chaput, L Verrièle, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 24, 2000
An innovative method for rapid characterisation of phospholipase C activity: SB242,084 competitively antagonises 5-HT2C receptor-mediated [3H]phosphatidylinositol depletionD Cussac, A Newman-Tancredi, Y Quentric, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 2000
[3H]S33084: a novel, selective and potent radioligand at cloned, human dopamine D3 receptorsD Cussac, A Newman-Tancredi, L Sezgin, et al.
European Journal of Pharmacology|July 27, 2001
Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinaseM J Millan, A Newman-Tancredi, D Duqueyroix, et al.
Psychopharmacology|July 24, 2001
The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptorsM J Millan, A Newman-Tancredi, Y Quentric, et al.
Pageof 50

Showing results (151-160 of 496) with videos related to

Sort By:
Pageof 50
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1989
Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of actionM J Millan, A Członkowski, A Lipkowski, et al.
European Journal of Pharmacology|October 18, 1988
Antinociceptive effects of mu- and kappa-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanismC Stein, M J Millan, A Yassouridis, et al.
Journal of Neurochemistry|May 30, 2007
Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formationFrancesca Novi, Mark J Millan, Giovanni U Corsini, et al.
Acta Leprologica|January 1, 1986
[HLA and leprosy in Dakar: distribution of histocompatibility antigens in leprous patients and their relationship to ENL reactions]G Blavy, D Thiam, B Ndoye, et al.
British Journal of Pharmacology|November 11, 1999
Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: antagonism of the effects of clozapine by modafinilC Sebban, B Tesolin-Decros, M J Millan, et al.
European Journal of Pharmacology|June 20, 1996
S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptorsA Newman-Tancredi, C Chaput, L Verrièle, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 24, 2000
An innovative method for rapid characterisation of phospholipase C activity: SB242,084 competitively antagonises 5-HT2C receptor-mediated [3H]phosphatidylinositol depletionD Cussac, A Newman-Tancredi, Y Quentric, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 2000
[3H]S33084: a novel, selective and potent radioligand at cloned, human dopamine D3 receptorsD Cussac, A Newman-Tancredi, L Sezgin, et al.
European Journal of Pharmacology|July 27, 2001
Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinaseM J Millan, A Newman-Tancredi, D Duqueyroix, et al.
Psychopharmacology|July 24, 2001
The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptorsM J Millan, A Newman-Tancredi, Y Quentric, et al.
Pageof 50